ST
SIOX

Spot Trading’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Spot Trading’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-650
Closed -$67K – 4193
2015
Q3 		$67K Buy
+650
New +$76.2K ﹤0.01% 3187

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return

Spot Trading's SIOX Position: Q1 2017 in Review

Spot Trading sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2017, closing a stake of 262 shares — an estimated $26K sold.

Spot Trading first reported a position in SIOX in Q3 2015 and held it in 3 quarters. The position peaked at $26K in Q4 2016. 97 funds tracked by Wall St. Rank hold SIOX as of Q1 2017.

  • Spot Trading reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 262 Sio Gene Therapies Inc. Common Stock shares in Q1 2017, an estimated $26K.
  • Spot Trading first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 3 quarters.
  • Spot Trading's Sio Gene Therapies Inc. Common Stock position peaked at $26K in Q4 2016.
  • 97 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.